OCEAN BIOMEDICAL, a biopharmaceutical company launched out of Brown University, is entering its first in-human clinical trial with with Virion Therapeutics LLC, a Delaware-based company that is moving to Philadelphia.
PROVIDENCE – Ocean Biomedical, a biopharmaceutical company launched out of Brown University, is entering its first in-human clinical trial with Virion Therapeutics LLC, a Delaware-based company that is moving to Philadelphia. Ocean Biomedical announced Thursday it is helping expand Virion’s clinical-stage program and pipeline of VRON-0200, a treatment for patients with chronic hepatitis B, a…
Thanks for reading Providence Business News.
Create your free account or log in to continue reading.
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.
